NewsMore in News→
Varda’s pharma deal tests whether drugmaking in orbit can become a real business
Key Takeaways
- Varda signed a collaboration with United Therapeutics to study drug development in microgravity.
- The deal is notable because it uses private corporate capital rather than NASA subsidy.
- The partnership will test whether orbital crystallization can improve stability and delivery of rare-disease treatments.
DE
DT Editorial Team··via arstechnica.com